Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-inhibitor to improve red blood cell transfusion efficacy in autoimmune hemolytic anemia
2012-003710-13Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of c1-esterase inhibitor in autoimmune haemolytic anaemia (AIHA), sponsored by Academic Medical Center. Primary endpoint: Recovery of red blood cell transfusion. Started Mar 2013; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
autoimmune haemolytic anaemia (AIHA)
Beyond the preview
Go deeper on 2012-003710-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003710-13.